It’s one thing to talk about the value of ESG, and another to make it part of how you do business. It’s the latter that you’ll be judged on.    As Cyn...

Crises come to even the best run organizations, and every leader — whether in management or on the board — needs to know how to react.    At the recen...

Now that we know vaccine mandates don’t lead to mass resignations, many more employers are taking the plunge. But there are still better and worse way...

ESG isn’t new, but for years it seemed more like a laudable goal than a business imperative. That’s obviously changing, and the mounting pressure to d...

Businesses and government leaders have been fighting vaccine hesitancy in a lot of ways these last few months, with varying degrees of success. Even a...

Like any move worth making, joining a board involves challenges and risks.   One of the big challenges, as Ken Banta pointed out in a recent conversat...

Most of us have felt frustration and anxiety this summer, as the early success of the vaccine rollout gave way to widespread hesitancy and the rise of...

Joseph LaRosa has thought a lot lately about both leading and lawyering under pressure.    Joe is General Counsel of Regeneron Pharmaceuticals, which ...

A few weeks back, we shared ideas for navigating the minefield of vaccine policy from Art Caplan, one of the country’s leading bioethicists. Art had v...

In early August, Ken Banta launched the Vanguard Vaccination Project in partnership with Glenna Brooks and Sherry Fox of Global Vaccination Advisors. ...

Vaccination policies can be a legal and ethical minefield for business leaders. In the video below, Art Caplan, one of the country’s top bioethicists,...

Entrepreneurial founders in life sciences often get derailed as they lead organizations into their third or fourth years. Vivek Ramaswamy, founder and...